Carcinoid Syndrome and Carcinoid Heart Disease as Manifestations of Non-Metastatic Ovarian Neuroendocrine Tumour.

Authors:
Lai Mun Wang
Lai Mun Wang
John Radcliffe Hospital
United Kingdom
Attila Kardos
Attila Kardos
Gottsegen Gyorgy Hungarian Institute of Cardiology
Hungary
Ashley Grossman
Ashley Grossman
Churchill Hospital

Acta Med Port 2017 May 31;30(5):421-425. Epub 2017 May 31.

Oxford Centre for Diabetes, Endocrinology and Metabolism. Churchill Hospital. Oxford. United Kingdom.

The carcinoid syndrome is rare but it is associated with carcinoid heart disease in more than a half of the cases. Carcinoid heart disease is typically characterised by morphological and functional modifications of right-sided valves. Its aetiology is probable multifactorial but serotonin appears to play a key role in the development of this valvular disease. Unlike gastrointestinal neuroendocrine tumours, ovarian neuroendocrine tumours can present with carcinoid syndrome and carcinoid heart disease in the absence of liver metastases; such ovarian neuroendocrine tumours are a unique clinical entity. The additional burden of cardiac impairment in these patients represents a significant reduction in survival. Early recognition and surgical valve replacement before advanced heart failure is established may improve the clinical outcome. We report the case of a woman with an ovarian neuroendocrine tumour and highly symptomatic carcinoid heart disease who was submitted to tumour resection followed by valvuloplasty. She demonstrated an outstanding clinical improvement and has remained free of tumour and symptomatology.

Download full-text PDF

Source
May 2017
10 Reads

Publication Analysis

Top Keywords

carcinoid heart
16
heart disease
12
carcinoid syndrome
12
syndrome carcinoid
8
neuroendocrine tumour
8
ovarian neuroendocrine
8
neuroendocrine tumours
8
carcinoid
7
disease
5
heart
5
disease absence
4
tumour highly
4
tumours carcinoid
4
metastases such ovarian
4
such ovarian neuroendocrine
4
case woman
4
ovarian neuroendocrine tumours
4
liver metastases
4
woman ovarian
4
absence liver
4

Similar Publications

Resolution of right-sided heart failure symptoms after resection of a primary ovarian carcinoid tumor.

Tex Heart Inst J 2014 Oct 1;41(5):533-6. Epub 2014 Oct 1.

Carcinoid tumors are rare neuroendocrine malignancies that typically originate from the gastrointestinal tract. Patients who are diagnosed with carcinoid heart disease generally have poor prognoses because of advanced metastases during staging and few therapeutic options. We present the case of a 61-year-old woman with right-sided heart failure, secondary to carcinoid heart disease caused by a primary ovarian carcinoid tumor. Read More

View Article
October 2014

Carcinoid heart disease--a hidden complication of neuroendocrine tumours.

Acta Gastroenterol Belg 2009 Jan-Mar;72(1):34-8

Department of Gastroenterology, University Hospital Gent, Gent, Belgium.

Carcinoid heart disease (CHD) develops in serotonin-producing neuroendocrine tumours (NET) due to fibrotic endocardial plaques with associated valve dysfunction leading most often to right-sided heart failure. The classical carcinoid syndrome usually occurs when serotonin-producing NET metastasize to the liver. Up to 50% of those patients will exhibit carcinoid heart disease. Read More

View Article
June 2009

Carcinoid Heart Disease without Liver Involvement Caused by a Primary Ovarian Carcinoid Tumour.

Heart Lung Circ 2015 Jul 24;24(7):e97-e100. Epub 2015 Feb 24.

Icahn School of Medicine, Mount Sinai Medical Center, NY, USA.

Carcinoid heart disease, caused by primary ovarian carcinoid tumour, is a rare form of valvular heart disease. This form of heart disease usually presents with symptoms of right-sided valvular dysfunction, ultimately leading to right-sided heart failure. This entity is unique as it develops in the absence of liver metastasis. Read More

View Article
July 2015

An unusual cause of carcinoid heart disease.

Acta Cardiol 2010 Dec;65(6):709-12

Department of Cardiology, Heilig-Hart Hospital, Roeselare, Belgium.

Carcinoid heart disease (CHD) is a rare form of valvular heart disease characterized by right-sided heart valve dysfunction. Carcinoid heart disease occurs most frequently when carcinoid tumour cells metastasize from a primary site in the gut to the liver, so that vasoactive substances produced by the tumour are able to reach the systemic circulation. By contrast, in ovarian carcinoid tumours carcinoid heart disease develops in the absence of liver metastasis, because vasoactive substances can be released directly into the systemic circulation, bypassing the first-pass metabolism of the liver. Read More

View Article
December 2010